Patents by Inventor Hossam H. Tayeb

Hossam H. Tayeb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Essential oil nanoemulsion and methods of use thereof
    Patent number: 11364199
    Abstract: An oil-in-water nanoemulsion is provided. The nanoemulsion contains 8-12% w/v essential oil, 1-5% w/v polysorbate 80 surfactant, 2-6% w/v glyceryl citrate/lactate/linoleate/oleate co-surfactant, and 1-5% w/v glycerol monocaprylate, type I, wherein a ratio of the surfactant and co-surfactant to essential oil is from 1:1.1 to 1:1.6. Methods of preparing the nanoemulsion and for the transdermal delivery of the nanoemulsion are also provided.
    Type: Grant
    Filed: November 9, 2021
    Date of Patent: June 21, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Hossam H. Tayeb, Raed Felimban, Nojod Hasaballah, Jwana Bin Mahfouz, Adeel Chaudhary, Majed Felemban, Fuad Alnadwi, Waleed Rizg
  • Methods for treating metabolic disorder
    Patent number: 11298321
    Abstract: Provided are a self-nanoemulsifying 3D printer ink composition and a method of using such composition to manufacture a 3D-printed tablet having compartmentalized active pharmaceutical ingredients. In particular, the 3D-printed tablet composition includes glimepiride and/or rosuvastatin in a curcuma oil based self-nanoemulsifying drug delivery system (SNEDDS). The disclosure also provides a method of treating a metabolic disorder or disease by administering a therapeutically effective amount of the 3D-printed tablet to a subject in need thereof.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: April 12, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Khalid M. El-Say, Tarek A Ahmed, Raed I. Felimban, Hossam H. Tayeb, Waleed Y Rizg, Fuad H. AlNadwi, Abdelsattar M. Omar
  • Self-nanoemulsifying 3D-printed tablet composition and method of use thereof
    Patent number: 11253481
    Abstract: Provided are a self-nanoemulsifying 3D printer ink composition and a method of using such composition to manufacture a 3D-printed tablet having compartmentalized active pharmaceutical ingredients. In particular, the 3D-printed tablet composition includes glimepiride and/or rosuvastatin in a curcuma oil based self-nanoemulsifying drug delivery system (SNEDDS).
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: February 22, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Tarek A. Ahmed, Raed I Felimban, Hossam H. Tayeb, Khalid M. El-Say, Waleed Y Rizg, Fuad H. Alnadwi